Aller au contenu principal
Profil bibliographique

Amie Rossi

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

7Publications signalées
58Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology ResearchNicotinic Acetylcholine Receptors StudyHemostasis and retained surgical itemsNeurotransmitter Receptor Influence on Behavior

Les publications récentes

Accès ouvert 2026 article OpenAlex

Safety and efficacy of flowable microfibrillar collagen hemostat in an ovine model of lumbar laminectomy and open durotomy compared with the gelatin-thrombin hemostatic matrix and control

Amie Rossi, Kasia Bradbury, Kingsley Abode-Iyamah, Angela Bohnen et autres

Background: Effective hemostasis in spinal surgery is critical, especially near sensitive structures such as the spinal cord and dorsal root ganglia. Flowable hemostatic agents offer targeted control in irregular, hard-to-reach areas. This study evaluates the safety and efficacy of flowable collagen hemostat …

us (code pays fourni par la source)

0 citations Frontiers in Surgery
Accès ouvert 2026 article OpenAlex

Safety and efficacy of flowable microfibrillar collagen hemostat in an ovine model of craniectomy with intraparenchymal defect compared to gelatin-thrombin hemostatic matrix

Darcy H. Gagne, Kasia Bradbury, Angela Bohnen, Kingsley O. Abode-Iyamah et autres

Flowable hemostatic agents offer advantages in confined surgical spaces, particularly in neurosurgery. However, data on microfibrillar collagen hemostats (MCH) in these applications remain limited. This study evaluated the safety and efficacy of a novel flowable collagen and compared to a gelatin-thrombin matrix—in …

us (code pays fourni par la source)

1 citation World Neurosurgery X
Accès ouvert 2024 article OpenAlex

Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M4 Muscarinic Acetylcholine Receptor

Christopher R. Butler, Michael Popiolek, Laura A. McAllister, Erik LaChapelle et autres

Selective activation of the M 4 muscarinic acetylcholine receptor subtype offers a novel strategy for the treatment of psychosis in multiple neurological disorders. Although the development of traditional muscarinic activators has been stymied due to pan-receptor activation, muscarinic receptor subtype selectivity can …

us (code pays fourni par la source)

20 citations Journal of Medicinal Chemistry
2017 article OpenAlex

[P3–046]: NOVEL NON‐CATECHOL D1 RECEPTOR AGONISTS EXHIBIT SUSTAINED PHARMACOLOGICAL ACTIVITY

Patrick L. Tierney, John Allen, Dmitri Volfson, Susan M. Lotarski et autres

Increasing evidence associates dysfunctional dopamine signaling with the motor and cognitive deficits in Alzheimer's disease. While D1 receptor (D1R) specific pathologies are reported, current D1R compounds have limited therapeutic potential due to their poor CNS penetration, negligible oral bioavailability, rapid metabolism and …

us (code pays fourni par la source)

0 citations Alzheimer s & Dementia
1967 article OpenAlex

Imidazoline Derivatives with Antiarrhythmic Activity

Lincoln H. Werner, S. Ricca, Amie Rossi, George deStevens

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTImidazoline Derivatives with Antiarrhythmic ActivityL. H. Werner, S. Ricca, A. Rossi, and George. deStevensCite this: J. Med. Chem. 1967, 10, 4, 575–582Publication Date (Print):July 1, 1967Publication History Published online1 May 2002Published inissue 1 July 1967https://pubs.acs.org/doi/10.1021/jm00316a014https://doi.org/10.1021/jm00316a014research-articleACS PublicationsRequest reuse permissionsArticle Views235Altmetric-Citations21LEARN …

23 citations Journal of Medicinal Chemistry

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.